Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)
Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)
About this item
Full title
Author / Creator
Lu, Guang , Jin, Shikai , Lin, Suwen , Gong, Yuping , Zhang, Liwen , Yang, Jingwen , Mou, Weiwei and Du, Jun
Publisher
Germany: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Germany: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Peripheral T-cell lymphomas (PTCLs) are a group of highly aggressive malignancies with generally poor prognoses, and the first-line chemotherapy of PTCL has limited efficacy. Currently, several novel targeted agents, including histone deacetylase inhibitors (HDACis), have been investigated to improve the therapeutic outcome of PTCLs. Several HDACis...
Alternative Titles
Full title
Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_8a0e7ded7b2c47a1b6c886cc2649446d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8a0e7ded7b2c47a1b6c886cc2649446d
Other Identifiers
ISSN
1868-7083,1868-7075
E-ISSN
1868-7083,1868-7075
DOI
10.1186/s13148-023-01531-8
